Stock Earnings

Question 1

Biogen Inc의 주요 재무제표는 무엇인가요?

Accepted Answer

최신 재무제표(Form-10K)에 따르면, Biogen Inc의 총 자산은 $28,049이며, 순profit입니다.

Question 2

BIIB의 주요 재무 비율은 무엇인가요?

Accepted Answer

Biogen Inc의 유동비율은 2.47이고, 순이익률은 16.86, 주당 매출은 $66.31입니다.

Question 3

Biogen Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?

Accepted Answer

Biogen Inc largest revenue segment is Multiple Sclerosis, at a revenue of 4,349,800,000 in the most earnings release.For geography, United States is the primary market for Biogen Inc, at a revenue of 3,237,300,000.

Question 4

Biogen Inc은 수익성이 있나요?

Accepted Answer

yes, 최신 재무제표에 따르면 Biogen Inc의 순profit은 $1,632입니다.

Question 5

Biogen Inc에 부채가 있나요?

Accepted Answer

yes, Biogen Inc의 부채는 11,333입니다.

Question 6

Biogen Inc의 발행 주식은 몇 주인가요?

Accepted Answer

Biogen Inc의 총 발행 주식은 145.7주입니다.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	10,065	9,675	9,835	10,173	10,982	13,445
Revenue Growth (YoY)	5%	-2%	-3%	-7%	-18%	-6%
Cost of Revenue	2,492	2,208	2,409	2,278	2,110	1,805
Gross Profit	7,573	7,467	7,426	7,895	8,872	11,639
Selling, General & Admin	2,426	2,401	2,575	2,430	2,702	2,535
Research & Development	1,780	2,015	2,459	2,229	2,497	3,985
Operating Expenses	4,704	4,816	5,252	4,671	5,377	6,665
Other Non Operating Income (Expenses)	-12	-29	-3	-10	-6	3
Pretax Income	1,904	1,906	1,296	3,592	1,745	5,048
Income Tax Expense	295	273	135	633	53	992
Net Income	1,608	1,632	1,161	3,047	1,556	4,001
Net Income Growth	0%	41%	-62%	96%	-61%	-32%
Shares Outstanding (Diluted)	147.1	145.9	145.6	146	150	161
Shares Change (YoY)	1%	0%	0%	-3%	-7%	-14%
EPS (Diluted)	10.93	11.18	7.97	20.87	10.37	24.85
EPS Growth	-1%	40%	-62%	101%	-57.99%	-21%
Free Cash Flow	2,262	2,515	1,235	1,141	3,345	3,678
Free Cash Flow Per Share	15.37	17.23	8.48	7.81	22.3	22.84
Gross Margin	75.24%	77.17%	75.5%	77.6%	80.78%	86.56%
Operating Margin	28.5%	27.4%	22.1%	31.69%	31.82%	37%
Profit Margin	15.97%	16.86%	11.8%	29.95%	14.16%	29.75%
Free Cash Flow Margin	22.47%	25.99%	12.55%	11.21%	30.45%	27.35%
EBITDA	3,632	3,324	2,668	3,742	3,982	5,432
EBITDA Margin	36.08%	34.35%	27.12%	36.78%	36.25%	40.4%
D&A For EBITDA	763	673	494	518	487	457
EBIT	2,869	2,651	2,174	3,224	3,495	4,975
EBIT Margin	28.5%	27.4%	22.1%	31.69%	31.82%	37%
Effective Tax Rate	15.49%	14.32%	10.41%	17.62%	3.03%	19.65%

Biogen Inc (BIIB) Price

BIIB Stock Price Chart

BIIB Income

Follow-Up Questions